Plan Cosmetic Testing Before Promising a Launch Date
Separate stability, antimicrobial protection and efficacy evidence, then connect methods, samples and changes to the launch plan.
Our development perspective: Separate stability, antimicrobial protection and efficacy evidence, then connect methods, samples and changes to the launch plan.
Ask what the test answers first
A testing schedule is often reduced to one number. Stability examines change over storage and use; preservation assessment examines antimicrobial protection; efficacy work addresses a particular claim. They are not interchangeable, and a report date is not overall launch readiness.
Match stability to product risks
ISO/TR 18811 provides guidance rather than one universal set of conditions, durations and acceptance criteria. Choose a justified protocol for the format, pack, distribution and use. Define relevant appearance, odour, pH, rheology and chemical measurements with acceptance limits.[1]
Do not convert acceleration directly into shelf life
Heat and cycling can reveal risks, but an unseparated sample at one time point does not establish a complete shelf life. Assess accelerated and real-time information alongside formulation, packaging and prior knowledge. Relevant active assays may matter as much as appearance.
CSFSRI formulation development: connect product objectives with appropriate validation.
Preservation performance is not a single microbial count
Microbial quality and preservation efficacy answer different questions. ISO 11930 covers evaluation of antimicrobial protection, including efficacy testing and risk assessment. Low-risk status needs justification; an anhydrous or preservative-free label alone is not the assessment.[2]
Separate method duration from laboratory turnaround
Confirm the applicable method version, observation points, criteria, sample quantity and reporting lead time. Queues, preparation, investigations and review affect delivery. No single four- or six-week promise applies to every product, and required observations should not be shortened to fit a deadline.
Parallel work needs controlled sample versions
At suitable prototype maturity, decide which evaluations can run in parallel. Link every test to a batch, formula and pack version. Changes to preservation, fragrance, pH or packaging require assessment of which conclusions remain applicable and which need more work.
Manage dates through release conditions
Define the release conditions before compressing validation: required documents, acceptable results, exception authority and artwork lock. Include waiting, retesting and change time. Determine efficacy-evaluation needs from intended claims and applicable requirements rather than treating them as universally optional.
References and development perspective
We use the research and standards below to inform formulation decisions. We evaluate finished-product performance separately against the intended claims.
[1] ISO/TR 18811 — Stability testing guidance